The iShares Large Cap 10% Target Buffer Mar ETF (TENM) seeks to provide exposure to large-cap U.S. stocks while offering 10% downside protection over a one-year outcome period ending in March. This defined outcome ETF uses options strategies to buffer the first 10% of losses while capping upside gains at a predetermined level.
How It Works
TENM employs a sophisticated options overlay strategy that combines exposure to large-cap U.S. equities with protective put options and sold call options. The fund resets annually in March, establishing new buffer and cap levels based on prevailing market conditions. BlackRock actively manages the options positions to maintain the 10% downside buffer throughout the outcome period while limiting upside participation to the predetermined cap rate set at inception.
Key Features
- Provides 10% downside buffer protection, absorbing the first 10% of large-cap equity losses over the March-to-March outcome period
- Newly launched with March 2026 outcome period, offering fresh buffer and cap levels based on current market conditions
- Part of BlackRock's defined outcome suite, providing predictable risk-return profiles for tactical portfolio allocation
Risks
- This ETF can lose value beyond 10% if large-cap stocks decline more than the buffer amount, with losses accelerating dollar-for-dollar thereafter
- Upside gains are capped at a predetermined level set annually, potentially missing significant market rallies above the cap rate
- Options strategies create complexity and tracking error versus direct equity exposure, with performance dependent on options market conditions and timing
Who Should Own This
Best suited for conservative investors with 1-year time horizons seeking equity exposure with defined downside protection. Low-to-medium risk tolerance required, ideal as a satellite holding (5-15% allocation) for those wanting predictable outcomes. Perfect for investors approaching retirement or those seeking tactical equity exposure with known risk parameters during uncertain market periods.